DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

CFRA Maintains Strong Sell on Allscripts Healthcare, Lowers Price Target to $6

CFRA analyst Paige Meyer maintains Allscripts Healthcare (NASDAQ:MDRX) with a Strong Sell and lowers the price target from $9 to $6.

Benzinga · 03/03/2020 17:15

CFRA analyst Paige Meyer maintains Allscripts Healthcare (NASDAQ:MDRX) with a Strong Sell and lowers the price target from $9 to $6.